Living Cell Technologies saluted by bioscience peers

摘要

Dr George Slim, CEO of NZBIO, says the judges rewarded LCT for taking a complex, world-first treatment technology over some very tough regulatory hurdles to show considerable promise in human trials. "The company has a strong portfolio of follow on products and has recently entered into a partnership deal with a major international pharmaceutical company," the judges said. Dr Slim said it had been tough selecting the top bioscience company, because among the finalists there was a range of excellent businesses, all of which had different business models.